34 related articles for article (PubMed ID: 22768744)
1. Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma.
Reid EG; Suazo A; Lensing SY; Dittmer DP; Ambinder RF; Maldarelli F; Gorelick RJ; Aboulafia D; Mitsuyasu R; Dickson MA; Wachsman W;
Clin Cancer Res; 2020 Feb; 26(3):558-565. PubMed ID: 31624104
[TBL] [Abstract][Full Text] [Related]
2. CE: HIV-Associated Kaposi Sarcoma in the Combination Antiretroviral Therapy Era.
Mangusan RF; Ekwede I; Widell A
Am J Nurs; 2022 Dec; 122(12):32-40. PubMed ID: 36321823
[TBL] [Abstract][Full Text] [Related]
3. [Kaposi sarcoma in HIV patients: Response to antiretroviral treatment and chemotherapy].
Lasso M; Pérez J; Noriega L; Malebrán A; Espinoza S
Rev Med Chil; 2003 May; 131(5):483-90. PubMed ID: 12879808
[TBL] [Abstract][Full Text] [Related]
4. Letter: Penile Kaposi sarcoma: A case of complete resolution with highly active antiretroviral therapy alone.
Pinto-Almeida T; Torres T; Rosmaninho A; Sanches M; Alves R; Caetano M; Selores M
Dermatol Online J; 2011 Jun; 17(6):12. PubMed ID: 21696692
[TBL] [Abstract][Full Text] [Related]
5. Peginterferon alfa-2a for AIDS-associated Kaposi sarcoma: experience with 10 patients.
Rokx C; van der Ende ME; Verbon A; Rijnders BJ
Clin Infect Dis; 2013 Nov; 57(10):1497-9. PubMed ID: 23912848
[TBL] [Abstract][Full Text] [Related]
6. Response of AIDS-associated Kaposi sarcoma to highly active antiretroviral therapy alone.
Paparizos VA; Kyriakis KP; Papastamopoulos V; Hadjivassiliou M; Stavrianeas NG
J Acquir Immune Defic Syndr; 2002 Jun; 30(2):257-8. PubMed ID: 12045689
[No Abstract] [Full Text] [Related]
7. [AIDS-associated sarcoma Kaposi: features of clinical manifestations, dynamics on a background of antiretroviral therapy].
Iurchenko AV; Martynchuk NA; Vikhtiuk NV
Lik Sprava; 2011; (7-8):81-5. PubMed ID: 22768744
[TBL] [Abstract][Full Text] [Related]
8. AIDS related Kaposi's sarcoma presenting with palatal and eyelid nodule.
Joshi U; Ceena DE; Ongole R; Sumanth KN; Boaz K; Jeena Priy K; Srikan N
J Assoc Physicians India; 2012 Jul; 60():50-3. PubMed ID: 23405543
[TBL] [Abstract][Full Text] [Related]
9. Oral HIV-associated Kaposi sarcoma.
Pantanowitz L; Khammissa RA; Lemmer J; Feller L
J Oral Pathol Med; 2013 Mar; 42(3):201-7. PubMed ID: 22672182
[TBL] [Abstract][Full Text] [Related]
10. New developments in the etiopathogenesis and treatment of HIV-related Kaposi's sarcoma.
Whelan P; Scadden DT
Clin Dermatol; 2000; 18(4):469-77. PubMed ID: 11024314
[No Abstract] [Full Text] [Related]
11. New drug targets in Kaposi sarcoma.
Sullivan RJ; Pantanowitz L
Expert Opin Ther Targets; 2010 Dec; 14(12):1355-66. PubMed ID: 21043836
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
